Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Laposata

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Journal of Lipid Research|November 19, 2011
DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activitySarah W Njoroge, Michael Laposata, Waddah Katrangi, et al.
American Journal of Clinical Pathology|February 21, 2009
Evaluation of effectiveness of a computerized notification system for reporting critical valuesElisa Piva, Laura Sciacovelli, Martina Zaninotto, et al.
Biochimica Et Biophysica Acta|May 25, 2011
Increased Δ5- and Δ6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosisSarah W Njoroge, Adam C Seegmiller, Waddah Katrangi, et al.
The Journal of Nutritional Biochemistry|December 3, 2014
Polyunsaturated fatty acid supplementation reverses cystic fibrosis-related fatty acid abnormalities in CFTR-/- mice by suppressing fatty acid desaturasesSarah W Njoroge, Michael Laposata, Kelli L Boyd, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 24, 2006
Method to assess fatty acid ethyl ester binding to albuminCatherine A Best, Michael Laposata, Veronia G Proios, et al.
American Journal of Clinical Pathology|October 21, 2010
Professional quality assurance in laboratory medicine: what about the competency of laboratory directors?Michael Laposata, Maria A Proytcheva, Joe C Rutledge, et al.
Archives of Pathology & Laboratory Medicine|March 20, 2002
Laboratory diagnosis of dysfibrinogenemiaMark T Cunningham, John T Brandt, Michael Laposata, et al.
Alcoholism, Clinical and Experimental Research|June 5, 2002
Pathogenesis of alcoholic liver disease--recent advancesAmin A Nanji, Grace L Su, Michael Laposata, et al.
Academic Pathology|August 20, 2021
The Doctorate in Clinical Laboratory Sciences: A New Curriculum to Enhance the Connection of the Laboratory to Health Care ProvidersJose H Salazar, Christopher J Zahner, Vicki S Freeman, et al.
Alcoholism, Clinical and Experimental Research|January 25, 2008
Induction of apoptosis and necrosis in human peripheral blood mononuclear cells by fatty acid ethyl estersKhaled Alhomsi, Martin Selig, Tonci Sustic, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Journal of Lipid Research|November 19, 2011
DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activitySarah W Njoroge, Michael Laposata, Waddah Katrangi, et al.
American Journal of Clinical Pathology|February 21, 2009
Evaluation of effectiveness of a computerized notification system for reporting critical valuesElisa Piva, Laura Sciacovelli, Martina Zaninotto, et al.
Biochimica Et Biophysica Acta|May 25, 2011
Increased Δ5- and Δ6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosisSarah W Njoroge, Adam C Seegmiller, Waddah Katrangi, et al.
The Journal of Nutritional Biochemistry|December 3, 2014
Polyunsaturated fatty acid supplementation reverses cystic fibrosis-related fatty acid abnormalities in CFTR-/- mice by suppressing fatty acid desaturasesSarah W Njoroge, Michael Laposata, Kelli L Boyd, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 24, 2006
Method to assess fatty acid ethyl ester binding to albuminCatherine A Best, Michael Laposata, Veronia G Proios, et al.
American Journal of Clinical Pathology|October 21, 2010
Professional quality assurance in laboratory medicine: what about the competency of laboratory directors?Michael Laposata, Maria A Proytcheva, Joe C Rutledge, et al.
Archives of Pathology & Laboratory Medicine|March 20, 2002
Laboratory diagnosis of dysfibrinogenemiaMark T Cunningham, John T Brandt, Michael Laposata, et al.
Alcoholism, Clinical and Experimental Research|June 5, 2002
Pathogenesis of alcoholic liver disease--recent advancesAmin A Nanji, Grace L Su, Michael Laposata, et al.
Academic Pathology|August 20, 2021
The Doctorate in Clinical Laboratory Sciences: A New Curriculum to Enhance the Connection of the Laboratory to Health Care ProvidersJose H Salazar, Christopher J Zahner, Vicki S Freeman, et al.
Alcoholism, Clinical and Experimental Research|January 25, 2008
Induction of apoptosis and necrosis in human peripheral blood mononuclear cells by fatty acid ethyl estersKhaled Alhomsi, Martin Selig, Tonci Sustic, et al.
Pageof 11